Sandoz

Cyclophosphamide (Sandoz)

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Sandoz

Cyclophosphamide (Sandoz) HCPCS:

J9074

HCPCS Code Descriptor:

Injection, cyclophosphamide (sandoz), 5 mg

Category:

J Code

Cyclophosphamide (Sandoz) NDCs:

00781-3528-10, 00781-3529-10, 00781-3530-10,

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Oral

Cyclophosphamide (Sandoz) CPT Codes:

Some of the most common CPT administration codes for 'buy and bill' drugs can be found at the following link:

Potential NDC Listing Errors:

We have not identified any potential errors with the NDCs mapped to this HCPCS code.

About Cyclophosphamide (Sandoz):

Cyclophosphamide (Sandoz) is manufactured by Sandozand aligned to the J Code: J9074. Cyclophosphamide (Sandoz) is a Oncology medication administered via the Oral route of administration.

ACCESS PRICING AND MORE BY REGISTERING

J9074 Added Date:

April 1, 2024

J9074 Effective Date:

April 1, 2024

J9074 Termination Date:

HCPCS Active

We have not identified a manufacturer-published billing and coding guide for Cyclophosphamide (Sandoz)
Our team has not identified a source of patient assistance information for Cyclophosphamide (Sandoz)
Cyclophosphamide (Sandoz) prescribing information can be found at the link below:
Our team has not yet identified a source of side effect information for Cyclophosphamide (Sandoz).